OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
In response to increasing concern about drug safety, FDA has implemented several administrative and policy changes, inclduing the new Office of Pharmacoepidemiology and Statistical Science and a renewed focus on risk assessment.